Heterozygous deletions of Mll3 in mice also lead to acute myeloid leukemia, as hematopoietic stem cells fail to differentiate correctly and over-proliferate, implicating Mll3 in dose-dependent tumor suppression20. Here, KMT2C is linked to neoplasm.